Metboss 500mg/0.3mg Tablet ER
Marketer
Omex Healthcare
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Metboss 500mg/0.3mg Tablet ER
DiaBeta 500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adult patients. It effectively regulates blood glucose in individuals with diabetes. DiaBeta 500mg/0.3mg ER tablets should be administered with meals. Consistent daily dosing at the same time maximizes therapeutic benefit. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue this medication as prescribed, even with well-controlled blood sugar. Discontinuing treatment without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan that incorporates a balanced diet, regular physical activity, and weight management as recommended by your healthcare provider. Lifestyle modifications are crucial in diabetes control. Potential side effects, including nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are generally transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention. Your doctor can provide strategies to mitigate or manage any bothersome side effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should disclose this information to their doctor prior to commencing treatment. Pregnant or breastfeeding women require medical consultation before initiating therapy. Regular blood glucose monitoring is essential, along with potential blood tests to evaluate blood cell counts and liver function as directed by your physician.
Uses of Metboss 500mg/0.3mg Tablet ER
Managing type 2 diabetes
Major Benefits of Metboss 500mg/0.3mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Metboss 500mg/0.3mg Extended-Release tablets with a meal.
Common Side effects of Metboss 500mg/0.3mg Tablet ER:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Metboss 500mg/0.3mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume Metboss 500mg/0.3mg Extended-Release tablets with food.
How Metboss 500mg/0.3mg Tablet ER works:
Extended-release Metboss tablets (500mg/0.3mg) contain a dual antidiabetic drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metboss 500mg/0.3mg Tablet ER with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metboss tablets (500mg/0.3mg) might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metboss 500mg/0.3mg tablets are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Extended-release Metboss 500mg/0.3mg tablets typically do not impair driving ability. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if taken concurrently with other diabetes medications like sulfonylureas, insulin, or repaglinide.
KidneyCAUTION
Exercise caution when prescribing Metboss 500mg/0.3mg Extended-Release tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not receive Metboss 500mg/0.3mg Extended-Release tablets. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Metboss 500mg/0.3mg extended-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Metboss 500mg/0.3mg Tablet ER :
Should you forget a Metboss 500mg/0.3mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metboss 500mg/0.3mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently